Display options
Share it on

J Exerc Rehabil. 2017 Apr 30;13(2):124-129. doi: 10.12965/jer.1734966.483. eCollection 2017 Apr.

Treadmill exercise alleviates depressive symptoms in rotenone-induced Parkinson disease rats.

Journal of exercise rehabilitation

Mal-Soon Shin, Tae-Woon Kim, Jae-Min Lee, Yun-Hee Sung, Baek-Vin Lim

Affiliations

  1. School of Global Sport Studies, Korea University, Sejong, Korea.
  2. Department of Physiology, College of Medicine, Kyung Hee University, Seoul, Korea.
  3. Department of Physical Therapy, College of Health Sciences, Kyungnam University, Changwon, Korea.
  4. Division of Leisure & Sports Science, Department of Exercise Prescription, Dongseo University, Busan, Korea.

PMID: 28503522 PMCID: PMC5412483 DOI: 10.12965/jer.1734966.483

Abstract

Parkinson disease (PD) is characterized by selective loss of the dopaminergic neurons. The symptoms of depression following PD are closely associated with reduced activity of the serotonergic system in the dorsal raphe. We explored the antidepressive effect of exercise and its possible mechanism using the rotenone-induced PD rats. PD rats were induced by subcutaneously injection with rotenone for 14 days. The rats in the exercise groups were made to run on a treadmill for 30 min once a day during 14 consecutive days. Forced swimming test, immunohistochemistry for serotonin (5-hydroxytryptamine, 5-HT), tryptophan hydroxylase (TPH), and western blot for serotonin 1A (5-HT1A) receptor were conducted. Injection of rotenone induced PD rats. PD rats showed depressive state and treadmill exercise ameliorated this depressive state. 5-HT, TPH, and 5-HT1A receptor expressions in the dorsal raphe were suppressed by rotenone injection and treadmill exercise increased the expressions of 5-HT, TPH, and 5-HT1A receptor in the rotenone-injected rats. The present results show that treadmill exercise ameliorated depressive symptoms in the rotenone-induced PD rats. The antidepressive effect of treadmill exercise might be ascribed to the enhancement of serotonergic function through upregulation of 5-HT1A expression in the dorsal raphe.

Keywords: Parkinson disease; Rotenone; Serotonin; Serotonin 1A receptor; Treadmill exercise

Conflict of interest statement

CONFLICT OF INTEREST No potential conflict of interest relevant to this article was reported.

References

  1. Eur J Neurosci. 2000 Oct;12(10):3771-80 - PubMed
  2. Neuropsychopharmacology. 2003 Jan;28(1):119-25 - PubMed
  3. Biol Psychiatry. 1998 Aug 1;44(3):151-62 - PubMed
  4. Nat Rev Neurol. 2011 Dec 26;8(1):35-47 - PubMed
  5. Am J Epidemiol. 2002 Aug 15;156(4):328-34 - PubMed
  6. Mol Psychiatry. 2007 Apr;12(4):331-59 - PubMed
  7. Neurology. 2013 May 14;80(20):1850-5 - PubMed
  8. Biol Psychiatry. 2007 Jan 15;61(2):223-30 - PubMed
  9. J Clin Psychiatry. 1999;60 Suppl 2:12-7; discussion 18-20, 113-6 - PubMed
  10. Mov Disord. 2008 Sep 15;23 (12 ):1776-80 - PubMed
  11. Hum Psychopharmacol. 2000 Mar;15(2):113-135 - PubMed
  12. Neuroscience. 2007 Dec 5;150(2):404-12 - PubMed
  13. Neuropharmacology. 1999 Aug;38(8):1083-152 - PubMed
  14. Brain. 2008 Jan;131(Pt 1):120-31 - PubMed
  15. Oxid Med Cell Longev. 2012;2012:624925 - PubMed
  16. Psychiatr Clin North Am. 1997 Dec;20(4):723-39 - PubMed
  17. Brain Res. 2006 Jun 20;1095(1):154-8 - PubMed
  18. J Exerc Rehabil. 2017 Feb 28;13(1):30-35 - PubMed
  19. Prog Neurobiol. 2011 Dec;95(4):614-28 - PubMed
  20. Neuron. 2000 Nov;28(2):335-41 - PubMed
  21. J Chem Neuroanat. 2003 Dec;26(4):331-43 - PubMed
  22. J Exerc Rehabil. 2017 Feb 28;13(1):36-42 - PubMed
  23. Prog Neurobiol. 2009 May;88(1):17-31 - PubMed
  24. Neuroreport. 2010 Mar 10;21(4):309-12 - PubMed
  25. J Biomed Biotechnol. 2012;2012:845618 - PubMed
  26. Behav Brain Res. 2014 Sep 1;271:343-53 - PubMed
  27. Biol Psychiatry. 2005 Mar 1;57(5):559-68 - PubMed
  28. Arch Gen Psychiatry. 2004 Aug;61(8):765-73 - PubMed

Publication Types